More specific insecticides: harnessing knowledge of insect receptors
Pest control is a central component of agriculture. However, insecticides and agriculture can have an impact on ecosystems. Regulations have been taken in Europe to ban some insecticides, based on the possible threat they pose to...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
EUIN2015-62604
APROXIMACIONES MOLECULARES PARA EL DISEÑO FUNGICIDAS RACIONA...
15K€
Cerrado
PCI2018-092893
BIOPRODUCCION SOSTENIBLE DE FEROMONAS DE INSECTOS PARA CONTR...
197K€
Cerrado
AGL2016-76516-R
HERRAMIENTAS PARA LA DETECCION Y EL MANEJO PROACTIVO DE LA R...
242K€
Cerrado
AGL2009-13452-C02-02
DESARROLLO DE ANTAGONISTAS DE FEROMONAS SEXUALES Y CARACTERI...
73K€
Cerrado
AGL2010-18286
DISEÑO Y PREPARACION DE FORMULACIONES DE LIBERACION CONTROLA...
73K€
Cerrado
AGL2008-01137
APROVECHAMIENTO DEL POTENCIAL DE BIOCONTROL DE LOS HONGOS EN...
133K€
Cerrado
Información proyecto LessToxCites
Duración del proyecto: 21 meses
Fecha Inicio: 2023-02-27
Fecha Fin: 2024-11-30
Descripción del proyecto
Pest control is a central component of agriculture. However, insecticides and agriculture can have an impact on ecosystems. Regulations have been taken in Europe to ban some insecticides, based on the possible threat they pose to pollinators. There is an urgent, unmet need for species-specific insecticides that are safe for non-target organisms. In the proposed proof-of-concept project, we aim at demonstrating that peptides specifically designed against neurotransmitter receptors can be potent at pest species without affecting beneficial species.
During the previous ERC-StG project, we developed tools to obtain pure mammalian neurotransmitter receptors. We have adapted those tools for insect receptors, which are the most important insecticide targets. We here propose to use insect receptors for the selection of species-specific peptides. The peptide libraries will be designed by computational-guided mutagenesis and screened by yeast display.
Within the project, we aim to secure a solid IP position on the technology platform we will build, in order to maximise the likelihood of success for a commercial endeavour. We will explore the market opportunity and regulatory pathway for subsequent product development, in order to define a business model and implement early commercialisation steps.